Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
1 093,811 096,521 100,221 091,51
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
608,77608,77612,97608,77
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
1 254,811 253,011 253,871 226,33
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
1 761,111 764,271 766,881 744,71
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
642,58644,87648,48640,18
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
851,13855,66858,75845,56
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
217,98217,98218,65216,88
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
3 211,833 227,213 268,383 226,55
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
948,98948,58957,83941,97
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
1 474,521 479,031 481,041 466,80
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
2 392,122 396,952 421,222 382,32
NBTX:NASDAQ
Nanobiotix SA - ADR
USD 35,12
+1,44%
(+0,50) 1D
1 Mei, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBTX...
Open
USD 34,99
High
USD 35,94
Low
USD 34,32
Mkt. cap
1,65 mjd
Avg. vol.
70,57 k
Volume
76,46 k
52-wk high
USD 41,89
52-wk low
USD 3,13
EPS
-USD 0,59
Beta
0,62
Shares outstanding
48,40 m
No. of employees
97
News stories
From sources across the web
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA - ADR
CEOLaurent Levy
Employees97
Founded2003
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
13,32 m
13,32 m
2,98 m
2,98 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7,26 m
7,26 m
4,29 m
4,29 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,65 m
5,65 m
4,53 m
4,53 m
Operating expense
12,91 m
12,91 m
8,83 m
8,83 m
Total operating expenses
12,91 m
12,91 m
8,83 m
8,83 m
Operating income
407,50 k
407,50 k
-5,85 m
-5,85 m
Other non operating income
500,00
500,00
-8,50 k
-8,50 k
EBT including unusual items
-2,69 m
-2,69 m
-9,29 m
-9,29 m
EBT excluding unusual items
-3,20 m
-3,20 m
-8,57 m
-8,57 m
Income tax expense
3,00 k
3,00 k
-1,50 k
-1,50 k
Effective tax rate
-0,11%
-0,11%
0,02%
0,02%
Other operating expenses
-
-
-
-
Net income
-2,69 m
-2,69 m
-9,29 m
-9,29 m
Net profit margin
-20,21%
-20,21%
-311,97%
-311,97%
Earnings per share
-
-
-
-
Interest and investment income
299,00 k
299,00 k
193,50 k
193,50 k
Interest expense
-2,12 m
-2,12 m
-3,08 m
-3,08 m
Net interest expenses
-1,82 m
-1,82 m
-2,88 m
-2,88 m
Depreciation and amortization charges
-
-
-
-
EBITDA
545,50 k
545,50 k
-5,79 m
-5,79 m
Gain or loss from assets sale
-
-
76,50 k
76,50 k
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more